Evidence map›Paper›PMID 40529013›Full record

ReviewTranslational andrology and urology2025

Adjustable continence therapy for men (ProACT

Adrian M Fernandez, Hiren V Patel, Kevin D Li, Ashwin S Balakrishnan, John Buie, Umar Ghaffar, Nizar Hakam, Benjamin N Breyer

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Adjustable continence therapy (ProACTTranslational andrology and urology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Adrian M FernandezDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-9918-5783
Hiren V PatelDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Kevin D LiDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Ashwin S BalakrishnanDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
John BuieDepartment of Urology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Umar GhaffarDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Nizar HakamDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Benjamin N BreyerDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adjustable continence therapy for men (ProACT Methods: Thirty-one peer-reviewed publications studying ProACT Results: Of 1,607 patients treated in published studies, 752 AEs occurred. The most common were mechanical failure (n=224, 30%), device migration/malposition (n=155, 21%), and device erosion (n=120, 16%). Devices were explanted in 24% of patients and revised or reimplanted in 28% of cases. In the MAUDE database, the AEs identified were similar, with most common complications including device erosion (n=32, 49%), surgical site infection (n=15, 19%), and urinary retention (n=9, 11%). Conclusions: Use of the ProACT

Indexed as

adjustable continence therapy (ProACT)male incontinenceManufacturer and User Facility Device Experience database (MAUDE database)Stress urinary incontinence (SUI)

Identifiers

PMID40529013
PMCPMC12170195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.